comparemela.com
Home
Live Updates
IBM, Boehringer partner on genAI, foundation models for therapeutic antibody research : comparemela.com
IBM, Boehringer partner on genAI, foundation models for therapeutic antibody research
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.
Related Keywords
Germany
,
German
,
Scala Biodesign
,
Andrew Nixon
,
Pfizer
,
Ibm
,
Astrazeneca
,
Boehringer Ingelheim
,
comparemela.com © 2020. All Rights Reserved.